SMARCB1 and neoplasm: In our clinical case SMARCB1 was not mutated in the germline DNA and the partial deletion of chromosome 22 not involving the SMARCB1 gene, nevertheless the immunohistochemistry of the AT/RT tumor of our patient demonstrated the absence of the SMARCB1 protein (Figure 3B), suggesting the loss of both alleles.